Header Logo

Connection

ELIAS JOSEPH JABBOUR to Immunoglobulin Variable Region

Back to Details
This is a "connection" page, showing publications ELIAS JOSEPH JABBOUR has written about Immunoglobulin Variable Region.
ELIAS JOSEPH JABBOUR
Connection Strength
0.189
Immunoglobulin Variable Region
  1. Ibrutinib, fludarabine, cyclophosphamide, and obinutuzumab (iFCG) regimen for chronic lymphocytic leukemia (CLL) with mutated IGHV and without TP53 aberrations. Leukemia. 2021 12; 35(12):3421-3429.
    View in: PubMed
    Score: 0.189
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.